Will Fry

Will Fry is the President at Antibodies Incorporated with extensive experience in antibody development, including mouse monoclonal, camelid single chain, and polyclonal antibody development. Will also has experience in hybridoma scale-up and antibody purification. Prior to this, Will held positions as a Post-doctoral fellow in Cancer Biology at Vanderbilt University Medical Center, Postdoctoral Fellow at UC Davis Medical Center, and completed consulting internships at Frontier Diagnostics and ACTIVENOW. Will holds a Ph.D. in Pharmacology and Toxicology from the University of California, Davis and an Honors Degree in Biochemistry from McGill University.